| Literature DB >> 35800287 |
Dou Mao1, Lijuan Fu2, Wenlan Zhang2.
Abstract
Background: Delirium often occurs in children with congenital heart disease in the early postoperative period, which is not conducive to the rehabilitation and prognosis. There is little evidence to prove the effectiveness and safety of drug treatment of delirium in children, and the prevention has become an important topic. The purpose of this study is to analyze the early risk factors of delirium in children after congenital heart surgery, establish a nomogram prediction model, and explore the application efficiency of the model, so as to provide reference for early prevention of delirium.Entities:
Keywords: Congenital heart surgery; children; delirium; nomogram; risk prediction model
Year: 2022 PMID: 35800287 PMCID: PMC9253935 DOI: 10.21037/tp-22-187
Source DB: PubMed Journal: Transl Pediatr ISSN: 2224-4336
Incidence of delirium
| Delirium | Number of patients | Percentage |
|---|---|---|
| Total | 92 | 25.4% |
| Subtypes | ||
| Hyperactive | 30 | 32.6% |
| Hypomanic | 20 | 21.7% |
| Mixed | 42 | 45.7% |
| Time of occurrence (days) | ||
| ≤2 | 77 | 83.7% |
| 2–7 | 15 | 16.3% |
| >7 | 0 | 0% |
| Delirium duration (days) | ||
| ≤2 | 72 | 78.3% |
| 2–7 | 19 | 20.7% |
| >7 | 1 | 1.1% |
| Outcome | ||
| Survived | 91 | 98.9% |
| Expired | 1 | 1.1% |
Comparison of risk factors related to delirium (n=362)
| Variable | Total (n=362) | Delirium (n=92) | Non delirium (n=270) | χ2/Z | P value |
|---|---|---|---|---|---|
| Preoperative risk factors | |||||
| Gender | 9.453 | 0.007 | |||
| Male | 186 (48.6) | 60 (34.8) | 126 (53.3) | ||
| Female | 176 (51.4) | 32 (65.2) | 144 (46.7) | ||
| Age, months | 12.85 (4.95, 28.93) | 5.95 (3.23, 15.10) | 15.65 (6.45, 34.45) | −5.282 | 0.000 |
| Cyanotic heart disease | 16.243 | 0.000 | |||
| Yes | 41 (11.0) | 21 (21.7) | 20 (7.4) | ||
| No | 321 (89.0) | 71 (78.3) | 250 (92.6) | ||
| Disease severity | 3 (3.00, 3.00) | 3 (3.00, 6.00) | 3 (1.00, 3.00) | −6.618 | 0.000 |
| Basic diseases affecting function | 2.376 | 0.059 | |||
| Yes | 21 (5.8) | 8 (9.8) | 12 (4.4) | ||
| No | 341 (94.2) | 84 (90.2) | 258 (95.6) | ||
| Dysplasia | 4.423 | 0.035 | |||
| Yes | 9 (2.5) | 5 (5.4) | 4 (1.5) | ||
| No | 353 (97.5) | 87 (94.6) | 266 (98.5) | ||
| Delirium in immediate family | / | / | |||
| Yes | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| No | 362 (100.0) | 92 (100.0) | 270 (100.0) | ||
| Delirium or cognitive impairment occurred previously | 0.685 | 0.408 | |||
| Yes | 2 (0.6) | 0 (0.0) | 2 (0.7) | ||
| No | 360 (99.4) | 92 (100.0) | 268 (99.3) | ||
| Albumin | 43 (40.30, 45.40) | 41.35 (38.18, 44.90) | 43.2 (41.10, 45.60) | −2.737 | 0.006 |
| Intraoperative risk factors | |||||
| Anesthesia | 14.998 | 0.091 | |||
| Sufentanil + midazolam + propofol + sevoflurane + esmeron + etomidate | 307 (84.8) | 71 (77.2) | 236 (87.4) | ||
| Sufentanil + midazolam + propofol + sevoflurane + esmeron + etomidate + atropine | 1 (0.3) | 0 (0.0) | 1 (0.4) | ||
| Sufentanil + midazolam + propofol + sevoflurane + esmeron + etomidate + lidocaine | 3 (0.8) | 1 (1.1) | 2 (0.7) | ||
| Sufentanil + midazolam + propofol + sevoflurane + esmeron + etomidate + ropivacaine | 1 (0.3) | 0 (0.0) | 1 (0.4) | ||
| Sufentanil + midazolam + propofol + sevoflurane + esmeron + etomidate + dexmedetomidine | 25 (6.9) | 8 (8.7) | 17 (6.3) | ||
| Sufentanil + midazolam + propofol + sevoflurane + esmeron | 1 (0.3) | 0 (0.0) | 1 (0.4) | ||
| Sufentanil + etomidate + propofol + esmeron + midazolam | 9 (2.5) | 6 (6.5) | 3 (1.1) | ||
| Sufentanil + etomidate + propofol + esmeron | 1 (0.3) | 1 (1.1) | 0 (0.0) | ||
| Sufentanil + etomidate + propofol + esmeron + sevoflurane | 14 (3.9) | 5 (5.4) | 9 (3.3) | ||
| Operation time, min | 135 (114.00, 165.00) | 150 (125.00, 190.00) | 135 (115.00, 160.00) | −3.605 | 0.000 |
| Cardiopulmonary bypass time, min | 59 (44.00, 75.75) | 65 (53.00, 100.00) | 56 (42.00, 70.50) | −4.147 | 0.000 |
| Aortic cross-clamp time, min | 32 (22.00, 46.00) | 38 (27.00, 57.50) | 30 (20.00, 44.00) | −2.745 | 0.001 |
| Cardiopulmonary bypass temperature | 14.096 | 0.007 | |||
| Normothermic | 197 (54.4) | 40 (43.5) | 157 (58.1) | ||
| Mild hypothermia | 115 (31.8) | 38 (41.3) | 77 (28.5) | ||
| Moderate hypothermia | 18 (5.0) | 9 (9.8) | 9 (3.3) | ||
| Deep hypothermia | 3 (0.8) | 0 (0.0) | 3 (1.1) | ||
| Nil | 29 (8.0) | 5 (5.4) | 24 (8.9) | ||
| Intraoperative blood transfusion | 2.845 | 0.092 | |||
| Yes | 336 (92.8) | 89 (96.7) | 247 (91.5) | ||
| No | 26 (7.2) | 3 (3.3) | 23 (8.5) | ||
| Use of cardiovascular active drugs | 1.983 | 0.159 | |||
| Yes | 339 (93.6) | 89 (96.7) | 250 (92.6) | ||
| No | 23 (6.4) | 3 (3.3) | 20 (7.4) | ||
Data are shown as number (percentage) or median (interquartile).
Assignment of independent variables of delirium
| Independent variable | Assignment |
|---|---|
| Gender | Male =1; female =0 |
| Age | <6.5 months =1; ≥6.5 months =0 |
| Cyanotic heart disease | Yes =1; no =0 |
| Disease severity | ≥4 points =1; <4 points =0 |
| Dysplasia | Yes =1; no =0 |
| Albumin | <41.5 g/L =1; ≥41.5 g/L =0 |
| Operation time | ≥148 min =1; <148 min =0 |
| Cardiopulmonary bypass time | >50 min =1; ≤50 min =0 |
| Aortic cross-clamp time | >40 min =1; ≤40 min =0 |
| Cardiopulmonary bypass temperature | Nil =0; normothermic =1; mild hypothermia =2; moderate hypothermia =3; deep hypothermia =4 |
Multivariate logistic regression analysis for predicting delirium
| Variable | β value | Standard error | Wald | OR (95% CI) | P value |
|---|---|---|---|---|---|
| Constant | −1.284 | 0.292 | 19.395 | − | 0.000 |
| Gender | 0.580 | 0.287 | 4.085 | 1.786 (1.018−3.134) | 0.043 |
| Age | −1.497 | 0.294 | 25.854 | 0.224 (0.126−0.399) | 0.000 |
| Disease severity | 1.940 | 0.341 | 32.311 | 6.955 (3.564−13.576) | 0.003 |
| Operation time | 0.876 | 0.299 | 8.582 | 2.401 (1.336−4.315) | 0.000 |
OR, odds ratio; CI, confidence interval.
Figure 1Nomogram of risk prediction of delirium in children after congenital heart surgery. PRISM, The Pediatric Risk of Mortality.
Figure 2ROC curve for predicting delirium in children after cardiac surgery. ROC, receiver operating characteristic.